The creative content studio from the Financial Times
Bayer is actively investing in the bio revolution and commissioned a series of articles that highlighted the convergence of biology and digitalisation, and how new technologies can tackle challenges that humanity has struggled to address so far.
We created an animated article that looked at the technological revolution looming in the life sciences. Animations were used to make a more engaging reader experience whilst also highlighting key data facts.
